In the stress degradation studies of Fimasartan, one major unknown oxidative degradation impurity was identified by LC-MS. This impurity was separated by preparative HPLC. By spectral data analysis ( 1 H NMR, 13 C NMR, DEPT, MS/MS and IR), this impurity is characterized as 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-1,6 -dihydro-4-methyl-6-oxo-pyrimidin-5-yl)-N,N-dimethylacetamide. The details of stress studies, identification, isolation, characterization, formation and mechanism of this impurity are discussed and presented here.
INTRODUCTION
Fimasartan (FIMA) (Fig.-1) is an antihypertensive agent. It is ninth non-peptide angiotensin II receptor antagonist (ARB) 1 . It is also used for the treatment of heart failure. Fimasartan acts by blocking angiotensin II receptor type I (AT1 receptor). Fimasartan is pyrimidin-4(3H)-one derivative of losartan which is obtained by replacement of imidazole ring in losartan. Fimasartan has higher potency and longer duration than losartan. Fimasartan was approved in South Korea in September 9, 2010 . It is marketed as Kanarb by Boryung Pharmaceuticals in Korea. It is available as a tablet for oral use which contains 60 mg or 120 mg of Fimasartan potassium trihydrate 2 . It is approved in India by CDSCO in 2016. HPLC method has been developed for evaluation of stability and simultaneous determination of fimasartan and amlodipine in tablet dosage form 3 . UPLC tandem mass chromatographic method has been reported for determination of fimasartan in human plasma 4 . Literature has been reported on LC-MS method development for the estimation of fimasartan in human plasma [5] [6] [7] .Literature has been reported on pharmacokinetics and metabolite profiling of fimasartan 8 . Recently we have developed a stability indicating method development of Fimasartan 9 . Major degradation was observed in oxidative condition. The objective of this study was to identify the major degradation product in oxidative condition after its isolation and characterization by mass, NMR and IR. FIMASARTAN 
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Chromatographic separation was performed on Shimadzu (Shimadzu Corporation, Kyoto, Japan), a chromatographic system equipped with Shimadzu LC-20 AP binary pump and Shimadzu SPD-20A detector. Samples were injected through Rheodyne 7725 injector valve. Data acquisition was performed with Class VP software. Daisogel-SP-100-10-ODS-P column was used for isolation. The flow rate kept at 5ml/min. Detection was performed at 262nm. The mobile phase in LC-PDA was replaced with 0.1% formic acid and acetonitrile in the ratio of 45:55.
LC-MS
LC-MS was performed on LCQ fleet (Thermo Fischer Scientific instrument).The system was coupled with quaternary system delivery module in positive and negative ESI (Electro Spray Ionization). The nebulizer pressure was set at 20 psi. The gas temperature was set at capillary voltage 5500V using nitrogen gas and gas temperature was set at 250ºC using drying gas nitrogen at 30 psi pressure. Data acquisition was done with Xcalibur software. The mobile phase containing 10 mm phosphate buffer pH 3 in LC-PDA was replaced by 0.1 % formic acid and acetonitrile in the ratio of 45: 55 in LC-MS.
NMR Spectroscopy
1 H and 13 C NMR spectra of FIMA and its degradation product were recorded by using Bruker Avance II 400 NMR spectrometer that consisted of dual broad band probe and z-axis gradients. DMSO-d6 was used FIMASARTAN DRUG SUBSTANCE Charu P. Pandya and Sadhana J. Rajput as a solvent for analysis. 1 H and 13 C NMR chemical shifts were calculated on δ scale in ppm with respect to tetramethyl silane as internal standard (δ 0.00 ppm).
FT-IR Spectroscopy
FT-IR spectra were recorded as Schimadzu 8400s FT-IR spectrometer.
Isolation of Oxidative Degradation Sample
Our previous studies 9 have shown that FIMA undergoes extensive oxidative degradation. Efforts were made to use stronger conditions so as to achieve total degradation of FIMA and obtain the impurity in a pure state. For this, a solution of FIMA (500 mg) dissolved in 15mL of water and acetonitrile in 25mL of volumetric flask. To the solution was added 10 ml of 30% hydrogen peroxide. The solution for degradation was kept at room temperature for 48 hours.
RESULTS AND DISCUSSION

Confirmation of Full Degradation of FIMA
The oxidative degradation sample was diluted to the required concentration and analyzed with analytical high-performance liquid chromatography. The analytical HPLC chromatograms of FIMA is shown in Fig.  2 . FIMA eluted about a retention time of 7.3 min. HPLC chromatogram of a stressed sample of oxidative degradation sample is shown in Fig.-3 . Degradation product (DP) was eluted at 4.9 min and was found with a maximum degradation of 75.4%. The degradation product was purified by preparative HPLC. Fractions greater than 95% were collected together and concentrated on rotavapour to remove acetonitrile. The solution was kept in lyophilizer overnight. DP was obtained with colorless solid and was recrystallized with hot water. The isolated fraction was analyzed by analytical HPLC which shows complete removal of FIMA which confirms the presence of DP only which is shown in Fig.- 
Identification of Oxidative Degradation Sample by LC-MS
To get structural insight, the LC-MS analysis was carried out on the oxidatively stressed sample. The mass spectrum thus obtained showed a protonated molecular ion of degradation impurity at m/z 486 (Fig.-6) , whereas the FIMA displayed protonated molecular ion at m/z 502 (Fig.-5 ) Thus the degradation impurity DP has 16 amu less than the molecular ion of FIMA. The 1 H NMR, 13 C NMR and DEPT spectral data of degradation product were compared with those of FIMA in Table- 1. The numbering scheme for the NMR assignments is shown in Fig-1 . In 1 H NMR, a number of protons in FIMA and its degradation product is the same.As in 13 C -NMR, the presence of -C=S (Thione) group carbon at 27th position in FIMA , is 199 ppm . In DP, there is the disappearance of -C=S (Thione) group and formation of carbonyl group at 27th position is observed, which is indicated by the chemical shift at 168.98 ppm. DEPT spectrum of FIMA and DP shows the presence of four methyl groups (positive). DEPT spectrum of FIMA and DP reveals the presence of five methylene groups (negative). Thus the degradation impurity structure can be rationalized in terms of substitution of thio group by a carbonyl group. The electrospray ionization (ESI) mass spectrum of the DP (Fig. 6) showed a molecular ion peak at m/z, 486.25 amu [M+H] + in positive ion mode, whereas the FIMA (Fig.5) , exhibited protonated molecular ion at m/z 502. Thus the degradation impurity DP has 16 amu less than the molecular ion of FIMA indicating replacement of sulphur group by oxygen. IR absorption spectral DP FIMASARTAN DRUG SUBSTANCE Charu P. Pandya and Sadhana J. Rajput data of degradation impurity (Table-2 ) also supporting that formation of one carbonyl functional group at 1651cm -1 and disappearance of thione (-C=S) functional group at 1230 cm -1 . The IR (KBr) spectral data of the degradation impurity was compared with those of FIMA in Table-2 . From the spectral data, the structure of this degradation impurity is characterized as 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylacetamide with molecular formula C27H31N7O2 and molecular weight 485.25. 13 C DEPT 
Formation of Degradation Impurity
The degradation impurity formed in the presence of oxidative stress degradation is due to the replacement of sulphur by oxygen and formation of the carbonyl group. The probable fragmentation pathway is shown in Fig.-7 .
CONCLUSION
The major unknown oxidative degradation product was isolated and was characterized by using spectroscopic techniques namely NMR,ESI-MS and IR. The spectral studies indicate that C=S group is replaced by C=O during oxidative degradation. The hitherto unreported impurity has been identified as 2- 
